Enfuvirtide Acetate API Powder Manufacturer China | T20 Peptide Supplier CAS 159519-65-0
Core Selling Points
✅ First-in-class HIV-1 fusion inhibitor - blocks viral entry before replication
✅ 36-amino-acid gp41 HR2 mimetic - prevents six-helix bundle formation
✅ GMP-aligned linear peptide production
✅ HPLC purity ≥98% - LC-MS identity confirmed
✅ Batch COA, gram bulk and cold-chain export
What Is Enfuvirtide Acetate?
Trimeris and Roche first brought Enfuvirtide Acetate Powder to the market in 2003 as the first HIV-1 fusion inhibitor, and researchers still know it as T-20 or DP178. The peptide contains 36 amino acids in one chain, with an acetylated N-terminus and an amidated C-terminus, and it copies the HR2 region of the viral gp41 protein. HDM BIO produces this white to off-white solid as a high quality research peptide, with gram bulk, wholesale lots and customized packing available for antiviral entry and resistance laboratories.
The material is sold for in-vitro research only; it does not arrive as a reconstituted, ready-to-inject therapy.
Why Choose HDM BIO as Your Enfuvirtide Supplier?
- Batch documentation with every shipment - COA, MSDS and packing list included
- Correct identity - 36-residue peptide confirmed by LC-MS / HPLC
- High-purity peptide - high quality enfuvirtide acetate, HPLC purity ≥98%
- Customized service - bulk enfuvirtide acetate, OEM/ODM and private-label vial packing
- Professional manufacturer - Xi'an HDM Biotech Co., Ltd., No.6299 Lanchi Second Road, Xi'an, Shaanxi, China
Bulk Enfuvirtide Acetate Supply Options
| Supply Type | Availability |
|---|---|
| Evaluation sample (100 mg) | Yes |
| Starter order (1 g) | Yes |
| Gram-scale bulk (10 g / 50 g) | Yes |
| Wholesale enfuvirtide acetate (100 g and above) | On request |
| Customized specification | On request |
We confirm prices with each quotation, and they are negotiable based on order quantity.
What Should Buyers Verify Before Purchasing?
| Buyer Check | Documentation / Method | Purpose |
|---|---|---|
| Identity / CAS | COA / LC-MS / HPLC | Confirm 914454-00-5 |
| Sequence length | Peptide mapping | Confirm the 36-residue chain |
| Termini | LC-MS | Confirm N-acetyl and C-amide |
| HPLC purity | RP-HPLC | Confirm ≥98.0% |
| Peptide content | Assay | Confirm 95–105% |
| Related peptides | HPLC | Limit single and total impurities |
| Acetate content | Ion chromatography | Confirm the counter-ion |
| Water content | Karl Fischer | Confirm ≤8.0% |
Enfuvirtide Quality Specifications and Batch Documentation
Every batch is tested in HDM BIO's QC laboratory, and we provide a batch-specific COA with each shipment.
| Test Item | Specification | Result |
|---|---|---|
| Appearance | White to off-white powder | Off-white powder |
| Identification | LC-MS / HPLC, conform | Conform |
| HPLC Purity | ≥98.0% | 98.8% |
| Peptide Content | 95.0 – 105.0% | 98.3% |
| Single Related Peptide | ≤0.5% | 0.3% |
| Total Related Peptides | ≤2.0% | 1.0% |
| Water Content | ≤8.0% | 4.5% |
| Acetate Content | 4.0 – 8.0% | 6.0% |
| Conclusion | The product complies with the requirements | |
Antiretroviral Targets (Avoid Confusion)
| Product | Class | CAS | Point of Action |
|---|---|---|---|
| Enfuvirtide Acetate | Fusion inhibitor (peptide) | 914454-00-5 | gp41 HR1, membrane fusion |
| Maraviroc | Entry inhibitor (small molecule) | 376348-65-1 | CCR5 co-receptor |
| Raltegravir | Integrase inhibitor | 518048-05-0 | Viral DNA integration |
| Efavirenz | Reverse transcriptase inhibitor | 154598-52-4 | Reverse transcription |
Entry inhibitors act before the virus enters the cell, while reverse transcriptase and integrase drugs act on steps that happen later.
What Is Enfuvirtide Acetate Used For?
Virology groups put Enfuvirtide Acetate Powder to work in HIV-1 entry and fusion research.
- Membrane fusion blockade - gp41 six-helix bundle studies
- Cell–cell and virus–cell fusion assays
- Antiviral resistance research - HR1 mutation mapping
- Entry-inhibitor combination and salvage-therapy modeling
- Virology assay and screening-platform development
- Mechanism-of-action work alongside other antiretroviral classes
- Route - parenteral in clinical use; not orally active
This material is a research reagent; dosing in cell and animal work follows the published protocol.
Storage & Handling
- Storage: Keep sealed at −20°C, protected from light; long-term holding at −80°C
- Working solutions: Peptide solutions are unstable; freeze aliquots and avoid repeated freeze-thaw
- Reconstituted material: Hold at 2–8°C and use within 48 hours
- Handling: Weigh and prepare in a dry, low-dust environment
- Safety: For laboratory and antiviral R&D. Not for direct human administration
FAQ
Q: Can I test a small amount before a full gram?
A: Yes. A 100 mg evaluation vial is available, and it carries the same batch COA and LC-MS identity as the bulk lot.
Q: Do the documents support identity and purity release?
A: Yes. Batch COA is provided with every shipment, including HPLC purity and peptide content, and the full HPLC trace and LC-MS are available on request.
Q: How soon can a small order ship?
A: We have fresh stock, ready for immediate shipment.
Q: At which step does it block HIV-1?
A: It blocks the entry step. The peptide binds gp41 HR1 and stops the six-helix bundle that fuses the viral and cellular membranes, so the virus never enters the cell.
Q: How should I store the peptide and its solutions?
A: Keep the sealed powder at −20°C, or −80°C for long-term holding. Working solutions are unstable, so freeze them in aliquots and use reconstituted material within 48 hours at 2–8°C.
Q: Does resistance develop through gp41?
A: Yes. Resistant viruses carry mutations in the gp41 HR1 region, which weakens peptide binding, so resistance studies are a common use for this reagent.
Factory



Certificate

Shipping & Packing

Enfuvirtide Acetate for HIV Entry and Fusion Research
Send us your required gram amount, preferred vial size and delivery address, and the team will reply with a quotation and the batch COA. A 100 mg evaluation vial is available for first-time testing, and cold-chain export packing can be arranged to protect the peptide in transit.
[Request Sample] [Request CoA] [Get Bulk / Wholesale Quote]
Each shipment includes the COA, MSDS and packing list, with the HPLC trace and LC-MS confirmation available on request.
WhatsApp: +86 19991242181
Email: sales@hdmbio.com
This is a research peptide rather than a finished antiretroviral. Request Enfuvirtide Acetate Powder for your virology laboratory.
Hot Tags: enfuvirtide acetate powder, China enfuvirtide acetate powder manufacturers, suppliers, factory, Octreotide Powder, , , ,
















